Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US
Ambassador views Teva CEO as important player in potential vaccine alliance
Teva boss hits out at opioid lawsuits | Financial Times
Israel's Teva Pharm in talks to co-produce COVID-19 vaccines, CEO says
Does Teva Really Have $5 Billion In Debt Payments Due Next Year? (NYSE:TEVA) | Seeking Alpha
Teva CEO on decimated share price: "It's rational enough from a market point of view"
Teva Pharmaceuticals Names Kare Schultz As New CEO | Fortune
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges (2)
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Israeli Troubled Teva appoints Kare Schultz CEO
Where is Kåre Schultz? | Ctech
Amerikanske politikere angriber dansk topchefs kriseplan til 150 milliarder
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
A Look At Kare Schultz, The New CEO In Charge Of Teva
Kåre Schultz forlænger med Teva: Får op til 26 mio. kr. mere i løn - FINANS
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva expands sustainability notes issue to $5b - Globes
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
